Live
10x Genomics Blog10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 10,000 Shares - MarketBeat10x Genomics Blog10x genomics CEO Saxonov sells $288,908 in stock - Investing.com10x Genomics Blog10x Genomics (NASDAQ: TXG) CEO sells 15,000 shares under Rule 10b5-1 plan - Stock Titan10x Genomics Blog10x Genomics Inc (TXG) Trading 4.54% Higher on Mar 25 - GuruFocusFierceBiotechFDA approves Denali's Hunter syndrome drug, handing rare disease community a winBioPharma DiveMaze tumbles on positive data for kidney disease drugEndpoints NewsFDA gives Denali accelerated approval for rare disease drug10x Genomics BlogVanguard realigns reporting; subsidiaries to report TXG holdings (TXG) - Stock TitanEndpoints NewsMore changes ahead for Takeda with new CEO set to take reins10x Genomics BlogWhy 10x Genomics Stock Is Surging Right Now - TipRanksEndpoints NewsHow Seaport is hedging against failure in Phase 2b depression studyBioPharma DiveBeam posts positive data on base editing treatment for AATD
10x Genomics Blog Mar 25, 2026

10x Genomics (NASDAQ: TXG) CEO sells 15,000 shares under Rule 10b5-1 plan - Stock Titan

10x Genomics (NASDAQ: TXG) CEO sells 15,000 shares under Rule 10b5-1 plan - Stock Titan

Original
Body unavailable. Use the original source.

Directory

59 All